Study design between subjects

The study design should be a single dose, two-treatment, two-period crossover with adequate washout period between the two phases of the study. Equal numbers of subjects should be randomly assigned to each of the two dosing sequences. 

Some of the researchers who have experimented with synthesized mescaline, LSD, or psilocybin have remarked upon the similarity between drug-induced and spontaneous mystical experiences because of the frequency with which some of their subjects have used mystical and religious language to describe their experiences. These data interested the author in a careful examination and evaluation of such claims. An empirical study, designed to investigate in a systematic and scientific way the similarities and differences between experiences described by mystics and those facilitated by psychedelic drugs, was undertaken (Pahnke, 1966, 1967). First, a phenomeno-... 

Inflammation is an important factor in the development of cardiovascular disease. Most clinical studies involving inflammation parameters have been relatively small. The Nurses Health Study involving 727 women was the largest study designed to determine the effects of n-3 fatty acids on biomarkers of inflammation and endothelium activation (Lopez-Garcia et al., 2004). They found an inverse association between ALA intake and plasma concentrations of C-reactive protein (a marker for inflammation), Interlukin-6, and E-selectin. Bemelmans et al. (2004) also found an inverse association between C-reactive protein and ALA intake in a randomized, double-blind placebo-controlled study involving 103 hypercholesterolemic subjects. 

Greater practical difficulties In a paired design, each subject has to be studied twice. This may be slower to implement, especially if you need to leave a significant period of time between the two stages of the study. With human studies, there is also the problem that people may be less likely to volunteer if they know they will be experimented upon twice instead of just once. 

Recognition of a beneficial effect of exercise on the Incidence of CHD has led to numerous cross-sectional and longitudinal studies designed to examine the Influence of physical activity on major coronary risk factors, with particular emphasis on plasma lipids and lipoproteins. A number of comprehensive reviews have summarized these studies (14-18). In general. In cross-sectional studies, high density lipoprotein (HDL) cholesterol is elevated (14) and total plasma and very low density lipoprotein (VLDL) triglycerides are lower In endurance trained subjects than In sedentary control subjects (14). In a study of 23 top-level male athletes, Lehtonen and Vllkarl (19) found a statistically significant relationship between the number of kilometers that the athletes ran or skied weekly and their plasma HDL cholesterol concentration (P<0.05 r=0.554). Low density lipoprotein (LDL) cholesterol Is frequently lower, and plasma total cholesterol Is Inconsistently lower In trained subjects (19). 

In a well-controlled study designed to assess the influence of the type and amount of dietary lipid on plasma lipid concentrations in endurance athletes, Lukaskl et al. (46) reported that the plasma response to dietary lipid was not attenuated in men who were physically very active. In contrast, Qulg and associates (47) reported that plasma total cholesterol concentration was lower in subjects who exercised and who ate a diet containing 0.4 or 1.4 gm of cholesterol dally. Thus, the influence of diet on the relationship between exercise and plasma lipids remains equivocal. 

Another important consideration in designing mineral absorption experiments is the effect of adaptation to a specific type of diet or level of mineral. Iii mineral absorption studies conducted to date, increasing periods of adaptation to a diet or to a level of nutrient results in decreased variability between subjects. Absorption determined from a diet which is fed only at one meal or on one day may be very different from absorption studied after a period of adaptation to the diet is allowed. 

The precise use of the placebo will depend on the study design, e.g. whether crossover, when all patients receive placebo at some point in the trial, or parallel group, when only one cohort receives placebo. Generally, patients easily understand the concept of distinguishing between the imagined effects of treatment and those due to a direct action on the body. Provided research subjects are properly informed and freely give consent, they are not the subject of deception in any ethical sense but a patient... 

---